PALB2 and complete blood cell count: There is evidence supporting that PALB2-associated FBC, specifically those harboring PALB2 c.1592del (p.Leu531fs) PV, displays aggressive clinicopathological features, such as the absence of hormonal receptors expression, advanced stage at diagnosis, and high Ki67 expression.